Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218374 · ClinicalTrials.gov registry record · NA
Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00218374 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 60 participants.
The verdict
NCT00218374, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Individuals who reduce or stop use of opioid medications are at risk for developing hyperalgesia, which is an increased sensitivity to pain. This study will compare the effectiveness of dextromethorphan, gabapentin, and oxycodone at reducing hyperalgesia in individuals addicted to opioids who are concurrently receiving methadone treatment.
Interventions
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218374
The ClinicalTrials.gov registry entry for NCT00218374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gabapentin is the first listed.
NCT00218374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218374 about?
NCT00218374 is a clinical study titled "Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia". Individuals who reduce or stop use of opioid medications are at risk for developing hyperalgesia, which is an increased sensitivity to pain. This study will compare the effectiveness of dextromethorphan, gabapentin, and oxycodone at reducing hyperalgesia in individuals addicted to opioids who are co...
What is the current status of trial NCT00218374?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2006-10. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00218374?
The interventions under investigation include: Gabapentin (DRUG).
Who is sponsoring clinical trial NCT00218374?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.